Dose-Ranging Study to Assess the Safety, PK and Initial Antiviral Efficacy of NVR 3-778 in Chronic HBV Patients

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2015
This Phase 1b trial will assess the dose-related safety and PK profile of different doses of NVR 3-778 in patients with chronic hepatitis B. Additionally,changes in patients\' serum HBV DNA levels and other virologic efficacy parameters will be assessed.
Epistemonikos ID: a1a2a99762c1298beec431b70dbe7084e5d6f6bf
First added on: Mar 23, 2020